Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Increasing Levothyroxine Dose in Ramadan for Hypothyroidism
NCT06135948Phase 4Completed
- Sponsor
- Emirates Health Services
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levothyroxine sodium in hypothyroidism, sponsored by Emirates Health Services. Started Mar 2022; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT06135948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135948.